{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T13:54:48Z","timestamp":1789480488971,"version":"build-2803163510"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Hangzhou bio-medicine and health industry development support science and technology project","award":["No. 2021WJCY238"],"award-info":[{"award-number":["No. 2021WJCY238"]}]},{"name":"Medical and Technology Project of Zhejiang Province","award":["No.2021KY890"],"award-info":[{"award-number":["No.2021KY890"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-03888-x","type":"journal-article","created":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T09:56:15Z","timestamp":1746093375000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Triglyceride glucose waist circumference and non alcoholic fatty liver disease: a systematic review and meta analysis"],"prefix":"10.1186","volume":"25","author":[{"given":"Ziyi","family":"Xin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanlan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingwen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongmin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuhan","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenghui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiake","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,1]]},"reference":[{"issue":"4","key":"3888_CR1","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1111\/liv.15856","volume":"44","author":"R Song","year":"2024","unstructured":"Song R, Li Z, Zhang Y, Tan J, Chen Z. Comparison of NAFLD, MAFLD and MASLD characteristics and mortality outcomes in united States adults. Liver Int. 2024;44(4):1051\u201360.","journal-title":"Liver Int"},{"issue":"6","key":"3888_CR2","doi-asserted-by":"publisher","first-page":"103043","DOI":"10.1016\/j.arcmed.2024.103043","volume":"55","author":"E Amini-Salehi","year":"2024","unstructured":"Amini-Salehi E, Letafatkar N, Norouzi N, Joukar F, Habibi A, Javid M, Sattari N, Khorasani M, Farahmand A, Tavakoli S, et al. Global prevalence of nonalcoholic fatty liver disease: an updated review Meta-Analysis comprising a population of 78 million from 38 countries. Arch Med Res. 2024;55(6):103043.","journal-title":"Arch Med Res"},{"issue":"1","key":"3888_CR3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73\u201384.","journal-title":"Hepatology"},{"issue":"1","key":"3888_CR4","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12944-021-01506-9","volume":"20","author":"R Wang","year":"2021","unstructured":"Wang R, Dai L, Zhong Y, Xie G. Usefulness of the triglyceride glucose-body mass index in evaluating nonalcoholic fatty liver disease: insights from a general population. Lipids Health Dis. 2021;20(1):77.","journal-title":"Lipids Health Dis"},{"issue":"38","key":"3888_CR5","doi-asserted-by":"publisher","first-page":"4574","DOI":"10.2174\/1381612825666190117102111","volume":"24","author":"M Papatheodoridi","year":"2018","unstructured":"Papatheodoridi M, Cholongitas E. Diagnosis of Non-alcoholic fatty liver disease (NAFLD): current concepts. Curr Pharm Des. 2018;24(38):4574\u201386.","journal-title":"Curr Pharm Des"},{"issue":"9","key":"3888_CR6","doi-asserted-by":"publisher","first-page":"Itc65","DOI":"10.7326\/AITC201811060","volume":"169","author":"XJ Wang","year":"2018","unstructured":"Wang XJ, Malhi H. Nonalcoholic fatty liver disease. Ann Intern Med. 2018;169(9):Itc65\u201380.","journal-title":"Ann Intern Med"},{"issue":"2","key":"3888_CR7","doi-asserted-by":"publisher","first-page":"206","DOI":"10.2741\/4892","volume":"26","author":"S Raza","year":"2021","unstructured":"Raza S, Rajak S, Upadhyay A, Tewari A, Anthony Sinha R. Current treatment paradigms and emerging therapies for NAFLD\/NASH. Front Biosci (Landmark Ed). 2021;26(2):206\u201337.","journal-title":"Front Biosci (Landmark Ed)"},{"key":"3888_CR8","doi-asserted-by":"publisher","first-page":"443","DOI":"10.2147\/DMSO.S271882","volume":"14","author":"M Xue","year":"2021","unstructured":"Xue M, Yang X, Zou Y, Liu T, Su Y, Li C, Yao H, Wang S. A Non-Invasive prediction model for Non-Alcoholic fatty liver disease in adults with type 2 diabetes based on the population of Northern Urumqi, China. Diabetes Metab Syndr Obes. 2021;14:443\u201354.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"3","key":"3888_CR9","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1002\/hep.24452","volume":"54","author":"R Hernaez","year":"2011","unstructured":"Hernaez R, Lazo M, Bonekamp S, Kamel I, Brancati FL, Guallar E, Clark JM. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology. 2011;54(3):1082\u201390.","journal-title":"Hepatology"},{"issue":"5","key":"3888_CR10","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.jhep.2016.06.005","volume":"65","author":"PS Dulai","year":"2016","unstructured":"Dulai PS, Sirlin CB, Loomba R. MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: clinical trials to clinical practice. J Hepatol. 2016;65(5):1006\u201316.","journal-title":"J Hepatol"},{"issue":"5","key":"3888_CR11","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1053\/j.gastro.2018.12.036","volume":"156","author":"L Castera","year":"2019","unstructured":"Castera L, Friedrich-Rust M, Loomba R. Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease. Gastroenterology. 2019;156(5):1264\u2013e12811264.","journal-title":"Gastroenterology"},{"issue":"2","key":"3888_CR12","doi-asserted-by":"publisher","first-page":"362","DOI":"10.2337\/diacare.24.2.362","volume":"24","author":"A Katsuki","year":"2001","unstructured":"Katsuki A, Sumida Y, Gabazza EC, Murashima S, Furuta M, Araki-Sasaki R, Hori Y, Yano Y, Adachi Y. Homeostasis model assessment is a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes. Diabetes Care. 2001;24(2):362\u20135.","journal-title":"Diabetes Care"},{"key":"3888_CR13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-230X-6-33","volume":"6","author":"G Bedogni","year":"2006","unstructured":"Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, Tiribelli C. The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6:33.","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"3888_CR14","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12933-021-01305-7","volume":"20","author":"A Wang","year":"2021","unstructured":"Wang A, Tian X, Zuo Y, Chen S, Meng X, Wu S, Wang Y. Change in triglyceride-glucose index predicts the risk of cardiovascular disease in the general population: a prospective cohort study. Cardiovasc Diabetol. 2021;20(1):113.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3888_CR15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12944-017-0409-6","volume":"16","author":"S Zhang","year":"2017","unstructured":"Zhang S, Du T, Zhang J, Lu H, Lin X, Xie J, Yang Y, Yu X. The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease. Lipids Health Dis. 2017;16(1):15.","journal-title":"Lipids Health Dis"},{"issue":"5","key":"3888_CR16","first-page":"451","volume":"29","author":"YT Liu","year":"2021","unstructured":"Liu YT, Wang W, Tong J, Wang BY. [Relationship between triglyceride-glucose index and non-alcoholic fatty liver disease]. Zhonghua Gan Zang Bing Za Zhi. 2021;29(5):451\u20135.","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"issue":"1","key":"3888_CR17","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12944-021-01561-2","volume":"20","author":"G Sheng","year":"2021","unstructured":"Sheng G, Lu S, Xie Q, Peng N, Kuang M, Zou Y. The usefulness of obesity and lipid-related indices to predict the presence of Non-alcoholic fatty liver disease. Lipids Health Dis. 2021;20(1):134.","journal-title":"Lipids Health Dis"},{"key":"3888_CR18","doi-asserted-by":"crossref","unstructured":"Bockarie AS, Nartey YA, Nsiah P, Edzie EKM, Tuoyire D, Acquah S, Eliason S, Nkum B. Fatty liver biomarkers and insulin resistance indices in the prediction of non-alcoholic fatty liver disease in Ghanaian patients. Endocrinol Diabetes Metabolism 2023;6(6).","DOI":"10.1002\/edm2.456"},{"issue":"1","key":"3888_CR19","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s12933-024-02343-7","volume":"23","author":"Q Chen","year":"2024","unstructured":"Chen Q, Hu P, Hou X, Sun Y, Jiao M, Peng L, Dai Z, Yin X, Liu R, Li Y, et al. Association between triglyceride-glucose related indices and mortality among individuals with non-alcoholic fatty liver disease or metabolic dysfunction-associated steatotic liver disease. Cardiovasc Diabetol. 2024;23(1):232.","journal-title":"Cardiovasc Diabetol"},{"issue":"9","key":"3888_CR20","doi-asserted-by":"publisher","first-page":"e075413","DOI":"10.1136\/bmjopen-2023-075413","volume":"13","author":"R Yu","year":"2023","unstructured":"Yu R, Xie W, Peng H, Lu L, Yin S, Xu S, Hu Z, Peng XE. Diagnostic value of triglyceride-glucose index and related parameters in metabolism-associated fatty liver disease in a Chinese population: a cross-sectional study. BMJ Open. 2023;13(9):e075413.","journal-title":"BMJ Open"},{"key":"3888_CR21","doi-asserted-by":"publisher","first-page":"1083032","DOI":"10.3389\/fendo.2023.1083032","volume":"14","author":"H Peng","year":"2023","unstructured":"Peng H, Pan L, Ran S, Wang M, Huang S, Zhao M, Cao Z, Yao Z, Xu L, Yang Q, et al. Prediction of MAFLD and NAFLD using different screening indexes: A cross-sectional study in U.S. Adults. Front Endocrinol (Lausanne). 2023;14:1083032.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"3888_CR22","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1089\/met.2020.0109","volume":"19","author":"ME Khamseh","year":"2021","unstructured":"Khamseh ME, Malek M, Abbasi R, Taheri H, Lahouti M, Alaei-Shahmiri F. Triglyceride glucose index and related parameters (Triglyceride glucose-Body mass index and triglyceride glucose-Waist Circumference) identify nonalcoholic fatty liver and liver fibrosis in individuals with overweight\/obesity. Metab Syndr Relat Disord. 2021;19(3):167\u201373.","journal-title":"Metab Syndr Relat Disord"},{"issue":"3","key":"3888_CR23","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1007\/s12020-021-02815-w","volume":"74","author":"M Malek","year":"2021","unstructured":"Malek M, Khamseh ME, Chehrehgosha H, Nobarani S, Alaei-Shahmiri F. Triglyceride glucose-waist to height ratio: a novel and effective marker for identifying hepatic steatosis in individuals with type 2 diabetes mellitus. Endocrine. 2021;74(3):538\u201345.","journal-title":"Endocrine"},{"key":"3888_CR24","doi-asserted-by":"publisher","first-page":"951689","DOI":"10.3389\/fendo.2022.951689","volume":"13","author":"Y Xue","year":"2022","unstructured":"Xue Y, Xu J, Li M, Gao Y. Potential screening indicators for early diagnosis of NAFLD\/MAFLD and liver fibrosis: triglyceride glucose index-related parameters. Front Endocrinol (Lausanne). 2022;13:951689.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"3888_CR25","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1007\/s10620-024-08309-9","volume":"69","author":"ME Khamseh","year":"2024","unstructured":"Khamseh ME, Malek M, Jahangiri S, Nobarani S, Hekmatdoost A, Salavatizadeh M, Soltanieh S, Chehrehgosha H, Taheri H, Montazeri Z, et al. Insulin resistance\/sensitivity measures as screening indicators of Metabolic-Associated fatty liver disease and liver fibrosis. Dig Dis Sci. 2024;69(4):1430\u201343.","journal-title":"Dig Dis Sci"},{"issue":"5","key":"3888_CR26","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1089\/met.2023.0276","volume":"22","author":"AL Han","year":"2024","unstructured":"Han AL, Lee HK, Shin SR. Diagnostic performance of insulin resistance indices for identifying metabolic Dysfunction-Associated fatty liver disease. Metab Syndr Relat Disord. 2024;22(5):402\u20139.","journal-title":"Metab Syndr Relat Disord"},{"issue":"5","key":"3888_CR27","doi-asserted-by":"publisher","first-page":"e070189","DOI":"10.1136\/bmjopen-2022-070189","volume":"13","author":"M Chang","year":"2023","unstructured":"Chang M, Shao Z, Shen G. Association between triglyceride glucose-related markers and the risk of metabolic-associated fatty liver disease: a cross-sectional study in healthy Chinese participants. BMJ Open. 2023;13(5):e070189.","journal-title":"BMJ Open"},{"issue":"2","key":"3888_CR28","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.jhep.2017.09.003","volume":"68","author":"M Eslam","year":"2018","unstructured":"Eslam M, Valenti L, Romeo S. Genetics and epigenetics of NAFLD and NASH: clinical impact. J Hepatol. 2018;68(2):268\u201379.","journal-title":"J Hepatol"},{"issue":"5","key":"3888_CR29","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/s41575-020-0269-9","volume":"17","author":"J Aron-Wisnewsky","year":"2020","unstructured":"Aron-Wisnewsky J, Vigliotti C, Witjes J, Le P, Holleboom AG, Verheij J, Nieuwdorp M, Cl\u00e9ment K. Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders. Nat Rev Gastroenterol Hepatol. 2020;17(5):279\u201397.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3888_CR30","doi-asserted-by":"crossref","unstructured":"Chen J, Vitetta L. Gut microbiota metabolites in NAFLD pathogenesis and therapeutic implications. Int J Mol Sci 2020;21(15).","DOI":"10.3390\/ijms21155214"},{"issue":"1","key":"3888_CR31","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41387-024-00281-7","volume":"14","author":"A Vakilpour","year":"2024","unstructured":"Vakilpour A, Amini-Salehi E, Soltani Moghadam A, Keivanlou MH, Letafatkar N, Habibi A, Hashemi M, Eslami N, Zare R, Norouzi N, et al. The effects of gut Microbiome manipulation on glycemic indices in patients with non-alcoholic fatty liver disease: a comprehensive umbrella review. Nutr Diabetes. 2024;14(1):25.","journal-title":"Nutr Diabetes"},{"issue":"5","key":"3888_CR32","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.1097\/MS9.0000000000001740","volume":"86","author":"E Amini-Salehi","year":"2024","unstructured":"Amini-Salehi E, Samethadka Nayak S, Maddineni G, Mahapatro A, Keivanlou MH, Soltani Moghadam S, Vakilpour A, Aleali MS, Joukar F, Hashemi M, et al. Can modulation of gut microbiota affect anthropometric indices in patients with non-alcoholic fatty liver disease? An umbrella meta-analysis of randomized controlled trials. Ann Med Surg (Lond). 2024;86(5):2900\u201310.","journal-title":"Ann Med Surg (Lond)"},{"key":"3888_CR33","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.clnesp.2023.07.087","volume":"57","author":"A Mahapatro","year":"2023","unstructured":"Mahapatro A, Bawna F, Kumar V, Daryagasht AA, Gupta S, Raghuma N, Moghdam SS, Kolla A, Mahapatra SS, Sattari N, et al. Anti-inflammatory effects of probiotics and synbiotics on patients with non-alcoholic fatty liver disease: an umbrella study on meta-analyses. Clin Nutr ESPEN. 2023;57:475\u201386.","journal-title":"Clin Nutr ESPEN"},{"issue":"2","key":"3888_CR34","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1002\/hep.30429","volume":"70","author":"RS Khan","year":"2019","unstructured":"Khan RS, Bril F, Cusi K, Newsome PN. Modulation of insulin resistance in nonalcoholic fatty liver disease. Hepatology. 2019;70(2):711\u201324.","journal-title":"Hepatology"},{"key":"3888_CR35","doi-asserted-by":"crossref","unstructured":"Sakurai Y, Kubota N, Yamauchi T, Kadowaki T. Role of insulin resistance in MAFLD. Int J Mol Sci 2021;22(8).","DOI":"10.3390\/ijms22084156"},{"issue":"10","key":"3888_CR36","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1007\/s00125-017-4340-1","volume":"60","author":"E Isokuortti","year":"2017","unstructured":"Isokuortti E, Zhou Y, Peltonen M, Bugianesi E, Clement K, Bonnefont-Rousselot D, Lacorte JM, Gastaldelli A, Schuppan D, Schattenberg JM, et al. Use of HOMA-IR to diagnose non-alcoholic fatty liver disease: a population-based and inter-laboratory study. Diabetologia. 2017;60(10):1873\u201382.","journal-title":"Diabetologia"},{"issue":"12","key":"3888_CR37","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1016\/j.numecd.2020.07.041","volume":"30","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Ding X, Hua B, Liu Q, Gao H, Chen H, Zhao XQ, Li W, Li H. High triglyceride-glucose index is associated with adverse cardiovascular outcomes in patients with acute myocardial infarction. Nutr Metab Cardiovasc Dis. 2020;30(12):2351\u201362.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"8","key":"3888_CR38","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.metabol.2016.02.014","volume":"65","author":"M Mota","year":"2016","unstructured":"Mota M, Banini BA, Cazanave SC, Sanyal AJ. Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease. Metabolism. 2016;65(8):1049\u201361.","journal-title":"Metabolism"},{"issue":"1","key":"3888_CR39","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1210\/er.2012-1009","volume":"34","author":"KH Williams","year":"2013","unstructured":"Williams KH, Shackel NA, Gorrell MD, McLennan SV, Twigg SM. Diabetes and nonalcoholic fatty liver disease: a pathogenic duo. Endocr Rev. 2013;34(1):84\u2013129.","journal-title":"Endocr Rev"},{"issue":"7","key":"3888_CR40","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/0002-9149(94)90676-9","volume":"73","author":"MC Pouliot","year":"1994","unstructured":"Pouliot MC, Despr\u00e9s JP, Lemieux S, Moorjani S, Bouchard C, Tremblay A, Nadeau A, Lupien PJ. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol. 1994;73(7):460\u20138.","journal-title":"Am J Cardiol"},{"issue":"7504","key":"3888_CR41","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1136\/bmj.38429.473310.AE","volume":"330","author":"H Wahrenberg","year":"2005","unstructured":"Wahrenberg H, Hertel K, Leijonhufvud BM, Persson LG, Toft E, Arner P. Use of waist circumference to predict insulin resistance: retrospective study. BMJ. 2005;330(7504):1363\u20134.","journal-title":"BMJ"},{"issue":"5","key":"3888_CR42","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1210\/er.2019-00034","volume":"40","author":"MJ Watt","year":"2019","unstructured":"Watt MJ, Miotto PM, De Nardo W, Montgomery MK. The liver as an endocrine Organ-Linking NAFLD and insulin resistance. Endocr Rev. 2019;40(5):1367\u201393.","journal-title":"Endocr Rev"},{"key":"3888_CR43","doi-asserted-by":"publisher","first-page":"1188214","DOI":"10.3389\/fendo.2023.1188214","volume":"14","author":"X He","year":"2023","unstructured":"He X, Huang X, Qian Y, Sun T. A non-linear relationship between triglyceride glucose waist circumference and nonalcoholic fatty liver disease in a Japanese population: a secondary analysis. Front Endocrinol (Lausanne). 2023;14:1188214.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"3888_CR44","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1089\/met.2020.0092","volume":"19","author":"TH Raimi","year":"2021","unstructured":"Raimi TH, Dele-Ojo BF, Dada SA, Fadare JO, Ajayi DD, Ajayi EA, Ajayi OA. Triglyceride-Glucose index and related parameters predicted metabolic syndrome in Nigerians. Metab Syndr Relat Disord. 2021;19(2):76\u201382.","journal-title":"Metab Syndr Relat Disord"},{"issue":"1","key":"3888_CR45","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1186\/s12876-023-03007-8","volume":"23","author":"S Li","year":"2023","unstructured":"Li S, Feng L, Ding J, Zhou W, Yuan T, Mao J. Triglyceride glucose-waist circumference: the optimum index to screen nonalcoholic fatty liver disease in non-obese adults. BMC Gastroenterol. 2023;23(1):376.","journal-title":"BMC Gastroenterol"},{"key":"3888_CR46","doi-asserted-by":"publisher","first-page":"1308265","DOI":"10.3389\/fendo.2023.1308265","volume":"14","author":"AH Kim","year":"2023","unstructured":"Kim AH, Son DH, Lee YJ. Modified triglyceride-glucose index indices are reliable markers for predicting risk of metabolic dysfunction-associated fatty liver disease: a cross-sectional study. Front Endocrinol (Lausanne). 2023;14:1308265.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"3888_CR47","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1159\/000527595","volume":"16","author":"F Liu","year":"2023","unstructured":"Liu F, Chen S, Li X, Li S, Xiao Y, Han J, Tu Y, Bao Y, Bai W, Yu H. Obesity-Induced hepatic steatosis is partly mediated by visceral fat accumulation in subjects with overweight\/obesity: A Cross-Sectional study. Obes Facts. 2023;16(2):164\u201372.","journal-title":"Obes Facts"},{"issue":"1","key":"3888_CR48","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s12933-024-02287-y","volume":"23","author":"Y Min","year":"2024","unstructured":"Min Y, Wei X, Wei Z, Song G, Zhao X, Lei Y. Prognostic effect of triglyceride glucose-related parameters on all-cause and cardiovascular mortality in the united States adults with metabolic dysfunction-associated steatotic liver disease. Cardiovasc Diabetol. 2024;23(1):188.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3888_CR49","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12933-023-02115-9","volume":"23","author":"K Dang","year":"2024","unstructured":"Dang K, Wang X, Hu J, Zhang Y, Cheng L, Qi X, Liu L, Ming Z, Tao X, Li Y. The association between triglyceride-glucose index and its combination with obesity indicators and cardiovascular disease: NHANES 2003\u20132018. Cardiovasc Diabetol. 2024;23(1):8.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3888_CR50","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12933-024-02215-0","volume":"23","author":"X Wei","year":"2024","unstructured":"Wei X, Min Y, Song G, Ye X, Liu L. Association between triglyceride-glucose related indices with the all-cause and cause-specific mortality among the population with metabolic syndrome. Cardiovasc Diabetol. 2024;23(1):134.","journal-title":"Cardiovasc Diabetol"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03888-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-03888-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03888-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T11:02:55Z","timestamp":1746097375000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-03888-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,1]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3888"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-03888-x","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,1]]},"assertion":[{"value":"25 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"328"}}